James L. Sherley, M.D., Ph.D.Associate Scholar
James L. Sherley graduated from Harvard College in 1980 with a B.A. degree in biology; and he completed joint M.D. and Ph.D. degrees at the Johns Hopkins University School of Medicine in 1988. After post-doctoral studies in cancer cell molecular biology at Princeton University, he joined the Fox Chase Cancer Center as a principal investigator in 1991. In 1998, he joined the faculty of the future Department of Biological Engineering at Massachusetts Institute of Technology, where he undertook research and teaching in the areas of cancer cell molecular biology, tissue stem cell bioengineering, toxicology, and environmental health science until moving to Boston Biomedical Research Institute (BBRI) in 2007. As a Senior Member of BBRI’s research programs in Regenerative Biology and Cancer Biology, Dr. Sherley established an academic center for developing adult stem cell-based technologies for advancing cellular medicine. After leaving BBRI, in October 2013 he founded Asymmetrex, LLC, which he now directs as President and CEO. Asymmetrex has the mission of advancing technologies for stem cell medicine. The company recently developed the first method of determining the dosage of therapeutic adult stem cells. Dr. Sherley’s awards include 1993 Pew Biomedical Research Scholar, 2003 Ellison Medical Foundation Senior Scholar in Aging Research, and 2006 NIH Director’s Pioneer Award. He is also “PGP-10” in the Personal Genome Project at Harvard Medical School.
Like the end of slavery in America, this social reformation is inevitable. But how soon it will occur will depend on how long it takes for most Americans to recognize and insist on the simple moral truth about us all.
A Handbook of Bioethical Considerations Regarding Nascent Human Beings and Their Cells (Handbook II)
The purpose of this handbook is to provide a useful reference guide to understanding ethical and moral implications for scientific experimentation involving nascent human beings and cells derived from nascent human beings. In particular, the attributes of nascent human beings and cells derived from them are presented in the context of their moral significance and bioethics considerations regarding the permissibility of their use in biomedical research.
The purpose of this handbook is to provide a useful reference guide to understanding the biological nature and properties of nascent human beings and cells derived from nascent human beings.
The 14-day limit is related to the approximate time in normal human embryonic development when structures appear in developing human beings that are the earliest stages of the formation of the nervous system. This ethics agreement is the warned slippery slope of allowing experimentation on embryonic human beings at any stage of their life.
Here we evaluate the actions and policy changes made by the Trump administration that have been taken since his term in office and analyze the current standing of federal funds used to support fetal tissue research. First, we give a brief overview of how federal tax dollars are used to fund medical research in the U.S.
Black women have been experiencing induced abortions at a rate nearly 4 times that of White women for at least 3 decades, and likely much longer. The impact in years of potential life lost, given abortion’s high incidence and racially skewed distribution, indicates that it is the most demographically consequential occurrence for the minority population.
Adherence to the highest ethical standards in science and medicine serves all humanity, because it values the dignity of every human life and respects the consciences of all, without exploitation of any group.
Here, we expose and consider the false and misleading claims regarding human fetal tissue (HFT) in research from scientific, legal, and ethical points of view. We endeavor deeply to understand the depth of the injustice in this practice and what forces promote and maintain it; and by revealing and understanding these forces, we set forth how these inhumane practices can be ended.
Testimony of Dr. James Sherley, M.D., Ph.D. in Support of Missouri Bills regarding Humane Treatment of Aborted Fetal Remains
On February 23, the Missouri House Children and Families Committee heard five bills on issues stemming from the Center for Medical Progress’s undercover video exposé of Planned Parenthood, including: the sale and final disposition of aborted fetal remains, post-abortion tissue reporting requirements, and employee protections for whistleblowers. Among those who testified in support of the bills was Dr. James Sherley, M.D., Ph.D., a physician scientist with expertise in biomedical research, cancer biology, and adult stem cell engineering.